NLM Logo

davunetide MeSH Supplementary Concept Data 2023


MeSH Supplementary
davunetide
Unique ID
C425904
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C425904
Entry Term(s)
AL 108
AL 208
AL-108
AL-208
AL-408
AL108 cpd
AL208 cpd
D-NAP peptide
NAP peptide
NAPVSIPQ peptide
Registry Number
GF00K3IIWE
Heading Mapped to
*Oligopeptides
Frequency
127
Note
AL-108 is a nasal systemic formulation; AL-208 is an intravenous formulation; associated with glial proteins regulated by vasoactive intestinal peptide, are shown now to provide protective intervention in a model of fetal alcohol syndrome
Source
J Pharmacol Exp Ther 2001 May;297(2):774-9
Date of Entry
2001/05/17
Revision Date
2013/04/18
davunetide Preferred
D-NAP peptide Narrower
AL-408 Narrower
AL 108 Narrower
AL 208 Narrower
page delivered in 0.003s